abbv-637
Showing 1 - 1 of 1
Advanced Solid Tumors Cancer, Non Small Cell Lung Cancer (NSCLC) Trial in Worldwide (ABBV-637, Docetaxel, Osimertinib)
Recruiting
- Advanced Solid Tumors Cancer
- Non Small Cell Lung Cancer (NSCLC)
- ABBV-637
- +2 more
-
Boston, Massachusetts
- +32 more
Dec 9, 2022